# 4-aminopyridine for Skin Wound Healing

> **NCT06333171** · PHASE2 · RECRUITING · sponsor: **John Elfar** · enrollment: 150 (estimated)

## Conditions studied

- Wounds
- Wound of Skin
- Wound Heal
- Wounds and Injuries

## Interventions

- **DRUG:** 4-Aminopyridine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06333171
- **Lead sponsor:** John Elfar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-09
- **Final completion:** 2028-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333171, "4-aminopyridine for Skin Wound Healing". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06333171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*